Royce Ma

578 total citations
10 papers, 371 citations indexed

About

Royce Ma is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Royce Ma has authored 10 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 6 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in Royce Ma's work include CAR-T cell therapy research (5 papers), Viral Infectious Diseases and Gene Expression in Insects (3 papers) and Virus-based gene therapy research (2 papers). Royce Ma is often cited by papers focused on CAR-T cell therapy research (5 papers), Viral Infectious Diseases and Gene Expression in Insects (3 papers) and Virus-based gene therapy research (2 papers). Royce Ma collaborates with scholars based in United States, Russia and Slovakia. Royce Ma's co-authors include Malcolm K. Brenner, Madhuwanti Srinivasan, Helen E. Heslop, Maksim Mamonkin, Mitsuo Hashimoto, Jody L. Baron, Stephen L. Nishimura, Haruhiko Yanagisawa, Feiyan Mo and Norihiro Watanabe and has published in prestigious journals such as Blood, Nature Biotechnology and The Journal of Immunology.

In The Last Decade

Royce Ma

10 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Royce Ma United States 8 233 151 108 77 46 10 371
Bettina P. Iliopoulou United States 10 250 1.1× 323 2.1× 101 0.9× 43 0.6× 14 0.3× 15 531
Irene Olivera Spain 12 259 1.1× 360 2.4× 139 1.3× 55 0.7× 15 0.3× 24 544
Cecilia Barese United States 13 383 1.6× 381 2.5× 178 1.6× 149 1.9× 9 0.2× 25 674
Dawson Knoblock United States 7 337 1.4× 403 2.7× 194 1.8× 27 0.4× 16 0.3× 8 695
Jason Yu United States 8 328 1.4× 168 1.1× 164 1.5× 160 2.1× 10 0.2× 11 531
Sólrún Melkorka Maggadóttir United States 9 59 0.3× 124 0.8× 55 0.5× 69 0.9× 16 0.3× 16 224
Katrin Birkholz Germany 9 225 1.0× 185 1.2× 152 1.4× 86 1.1× 10 0.2× 19 362
Nobuhiko Imahashi Japan 14 306 1.3× 283 1.9× 111 1.0× 91 1.2× 5 0.1× 41 622
Anna Capsomidis United Kingdom 5 381 1.6× 397 2.6× 129 1.2× 85 1.1× 5 0.1× 7 622

Countries citing papers authored by Royce Ma

Since Specialization
Citations

This map shows the geographic impact of Royce Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Royce Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Royce Ma more than expected).

Fields of papers citing papers by Royce Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Royce Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Royce Ma. The network helps show where Royce Ma may publish in the future.

Co-authorship network of co-authors of Royce Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Royce Ma. A scholar is included among the top collaborators of Royce Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Royce Ma. Royce Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Ma, Royce, Mae Woods, Dayenne G. van Leeuwen, et al.. (2024). Chimeric antigen receptor-induced antigen loss protects CD5.CART cells from fratricide without compromising on-target cytotoxicity. Cell Reports Medicine. 5(7). 101628–101628. 5 indexed citations
2.
Hill, LaQuisa, Rayne H. Rouce, Meng-Fen Wu, et al.. (2023). Antitumor efficacy and safety of unedited autologous CD5.CAR T cells in relapsed/refractory mature T-cell lymphomas. Blood. 143(13). 1231–1241. 30 indexed citations
3.
Ma, Royce, et al.. (2022). T-cells resist CD5 CAR mediated fratricide by continuously degrading CD5 protein. The Journal of Immunology. 208(Supplement_1). 122.08–122.08. 1 indexed citations
4.
Watanabe, Norihiro, Feiyan Mo, Rong Zheng, et al.. (2022). Feasibility and preclinical efficacy of CD7-unedited CD7 CAR T cells for T cell malignancies. Molecular Therapy. 31(1). 24–34. 45 indexed citations
5.
Mo, Feiyan, Norihiro Watanabe, Mary K. McKenna, et al.. (2020). Engineered off-the-shelf therapeutic T cells resist host immune rejection. Nature Biotechnology. 39(1). 56–63. 111 indexed citations
6.
Albuquerque, José Antônio Tavares de, Pinaki P. Banerjee, Ângela Castoldi, et al.. (2018). The Role of AIRE in the Immunity Against Candida Albicans in a Model of Human Macrophages. Frontiers in Immunology. 9. 567–567. 10 indexed citations
7.
Takasaka, Naoki, Robert Seed, Anthony Cormier, et al.. (2018). Integrin αvβ8–expressing tumor cells evade host immunity by regulating TGF-β activation in immune cells. JCI Insight. 3(20). 89 indexed citations
8.
Yanagisawa, Haruhiko, Mitsuo Hashimoto, Shunsuke Minagawa, et al.. (2016). Role of IL-17A in murine models of COPD airway disease. American Journal of Physiology-Lung Cellular and Molecular Physiology. 312(1). L122–L130. 51 indexed citations
9.
Hashimoto, Mitsuo, Haruhiko Yanagisawa, Shunsuke Minagawa, et al.. (2015). TGF-β–Dependent Dendritic Cell Chemokinesis in Murine Models of Airway Disease. The Journal of Immunology. 195(3). 1182–1190. 19 indexed citations
10.
Hashimoto, Mitsuo, Haruhiko Yanagisawa, Shunsuke Minagawa, et al.. (2015). A Critical Role for Dendritic Cells in the Evolution of IL-1β–Mediated Murine Airway Disease. The Journal of Immunology. 194(8). 3962–3969. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026